On The Pen: The Weekly Dose

Follow On The Pen: The Weekly Dose
Share on
Copy link to clipboard

Get your weekly dose of everything in the news about incretin mimetic therapies, like Zepbound and Mounjaro, Ozempic and Wegovy, and even investigational treatments like CagriSema and Retatrutide!

Dave Knapp Man On The Mounjaro

Donate to On The Pen: The Weekly Dose


    • Jun 3, 2025 LATEST EPISODE
    • weekdays NEW EPISODES
    • 34m AVG DURATION
    • 120 EPISODES

    Ivy Insights

    The On The Pen: The Weekly Dose podcast is a fantastic addition to Dave's repertoire of content. As someone who follows him on Instagram but prefers a podcast format, I was thrilled when he announced the launch of this show. It provides the perfect opportunity for me to stay informed and entertained while I'm driving or cleaning. Right from the first episode, it is evident that the production quality is top-notch. The sound is crisp and clear, making for an enjoyable listening experience. Additionally, the inclusion of hyperlinks in the episode notes is greatly appreciated as it allows me to easily access additional resources mentioned during the show.

    One of the best aspects of The On The Pen podcast is Dave's ability to simplify complex concepts related to healthcare and make them accessible to anyone. In a field that can often be overwhelming with intricate details, he does an excellent job of breaking down information so that even those without a medical background can understand it. This approach makes his content valuable to a wide range of listeners who are seeking knowledge and empowerment.

    Another commendable aspect of this podcast is Dave's fair and unbiased reporting. While there are often controversial topics in healthcare, he remains neutral and presents information objectively. This allows listeners to form their own opinions based on facts rather than feeling swayed by personal biases or agendas.

    While it's challenging to find any major flaws in this podcast, one minor criticism would be that some episodes may not cater specifically to individual interests or needs. However, given the variety of topics covered in each episode, it is understandable that not every segment will resonate with every listener. Nevertheless, Dave's engaging style and ability to deliver information effectively compensate for any potential lack of interest in specific topics.

    In conclusion, The On The Pen: The Weekly Dose podcast is a must-listen for anyone looking for accessible and informative healthcare content. Dave's dedication to keeping his audience updated with accurate facts while maintaining an engaging delivery style sets this podcast apart. I highly recommend jumping on board early to join the ever-growing community of listeners who appreciate the valuable knowledge and motivation that Dave delivers.



    Search for episodes from On The Pen: The Weekly Dose with a specific topic:

    Latest episodes from On The Pen: The Weekly Dose

    Lilly Makes Bold Move on GLP Dosing / 8x More Ozempic? / Wegovy Use in Teens

    Play Episode Listen Later Jun 3, 2025 21:18


    VIEW ALL OF OUR LINKS: https://linktr.ee/manonthemounjaro JOIN OUR SUBSTACK: HTTP://WWW.ONTHEPEN.SUBSTACK.COM

    Trump Admin Setting Price Targets for Zepbound and Ozempic, Will Pharma Go Along?

    Play Episode Listen Later May 20, 2025 29:47


    Join the Substack here: onthepen.substack.com Get all my links here: https://linktr.ee/manonthemounjaro

    Zepbound vs. Wegovy, CVS vs. Patients, and the Executive Order That Changes Everything

    Play Episode Listen Later May 13, 2025 41:02


    Joe's Petition + All My Links: https://linktr.ee/manonthemounjaro

    Compound Tirzepatide Lawsuit + PBM Reform Update // OTP TWD 5.6.25

    Play Episode Listen Later May 6, 2025 26:31


    Dave discussed the latest update in the OFA vs FDA compound tirzepatide battle, as well as this weeks news in obesity medicine. Find our substack and all promotional links here: https://linktr.ee/manonthemounjaro

    CVS Drops Zepbound + Lilly Earnings Call Recap

    Play Episode Listen Later May 1, 2025 33:37


    CVS announces major partnership with Novo Nordisk as Lilly announces Q! 2025 earnings. Dave covers it all in today's breakdown. Join the Substack: https://substack.com/@onthepen WAYS TO SUPPORT MY WORK ⬇️

    Compound GLP-1 PubMed Data: What It Didn't Tell Us

    Play Episode Listen Later Apr 29, 2025 21:40


    Join the Substack: https://substack.com/@onthepen WAYS TO SUPPORT MY WORK ⬇️

    High Dose Semaglutide Incoming! How Much Will it Cost? // OTP TWD 4.22.25

    Play Episode Listen Later Apr 22, 2025 18:45


    Getting Insurance To Cover Skin Removal Surgery // OTP Eps 109

    Play Episode Listen Later Apr 19, 2025 64:02


    The Knapp family was featured in a health.com video! Watch it Here: https://www.health.com/beyond-obesity-glp1-8685599 WAYS TO SUPPORT MY WORK ⬇️

    Counterfeit Ozempic at Pharmacies! // OTP TWD 4.15.25

    Play Episode Listen Later Apr 15, 2025 14:43


    The Knapp family was featured in a health.com video! Watch it Here: https://www.health.com/beyond-obesity-glp1-8685599 WAYS TO SUPPORT MY WORK ⬇️

    GLP-1 Slow Responders: Dr Matthea Rentea // OTP Eps 108

    Play Episode Listen Later Apr 11, 2025 68:01


    The Knapp family was featured in a health.com video! Watch it Here: https://www.health.com/beyond-obesity-glp1-8685599 WAYS TO SUPPORT MY WORK ⬇️

    Grow-Zempic!? These Students Discoverd a GLP-1 Plant!

    Play Episode Listen Later Apr 11, 2025 19:08


    Noom CEO Geoff Cook Interview: Wall Street Journal GLP-1 Cost Ad

    Play Episode Listen Later Apr 9, 2025 27:58


    WAYS TO SUPPORT MY WORK ⬇️

    GLP-1 Medicare Coverage: What is Going On // OTP TWD 04.08.2025

    Play Episode Listen Later Apr 8, 2025 25:41


    Ozempic, Trulicity and Victoza are decreasing dementia by 45%, so what is going on with Medicare coverage for obesity medicine? The Knapp family was featured in a health.com video! Watch it Here: https://www.health.com/beyond-obesity-glp1-8685599 WAYS TO SUPPORT MY WORK ⬇️

    Are GLP-1 Meds For Life? Fractyl's CEO Says “Not So Fast!”

    Play Episode Listen Later Apr 6, 2025 27:35


    Fake Sugar:

    Play Episode Listen Later Apr 4, 2025 57:06


    Dave sits down with a favorite OTP guest, Dr. Spencer Nadolsky of the Docs Who Lift Podcast to discuss a recent study that asked, “Does Sucralose Increase Hunger?” Dr. Spencer gives his take. Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp

    Tirzepatide Compounds: Lilly Sues Pharmacies // OTP TWD 04.01.25

    Play Episode Listen Later Apr 1, 2025 37:06


    Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp

    Zepbound Weight Loss Stalls: Tips and Tricks // OTP Eps 106

    Play Episode Listen Later Mar 29, 2025 64:36


    Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp

    Rare Exclusive Interview: OFA Chairman Sits Down with OTP to Talk Tirzepatide Lawsuit

    Play Episode Listen Later Mar 26, 2025 32:20


    In this rare and exclusive interview, the chairman of the Outsourcing Facilities Association sits down with On The Pen to discuss the current landscape of compound tirzepatide. Www.503bs.org

    Novo's Retatrutide Competitor

    Play Episode Listen Later Mar 25, 2025 27:37


    Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp

    Ozempic: Setting the Microdosing Strategy Straight w/ Dr Tyna Moore // OTP EPS 105

    Play Episode Listen Later Mar 14, 2025 53:14


    ​⁠'s course, use code “OTP20” to save 20%! https://www.drtyna.com/offers/VstUywXc/checkout Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp

    Compound Tirzepatide Latest // Cagrisema Disappoints Again // Great Vikingtide News

    Play Episode Listen Later Mar 11, 2025 21:10


    Dave discusses the latest in the compound tirzepatide legal battles, cagrisema delivers more big let downs, and some exciting news about VK2735 aka Vikingtide Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp

    Obesity Bias in Medicine With Dr. Toomer // OTP Eps 104

    Play Episode Listen Later Mar 7, 2025 90:27


    Dr. Catherine Harmon Toomer is a board certified Family Medicine physician, certified hypnotherapist & NLP practitioner, founder of TOTAL Weight Care Institute™️ and Your Light Wellness & Weight Care Group. She provides comprehensive and compassionate alternative to the shame-to-change model & yo-yo progress too often experienced in wellness and weight health spaces. Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp

    Compound GLP-1 Accessibility + World Obesity Day // OTP TWD 03.04.25

    Play Episode Listen Later Mar 4, 2025 32:10


    The latest in compounded semaglutide and tirzepatide, as well as the meaning behind World Obesity Day Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp

    Compound Tirzepatide Latest Updates // @Mike.OnAMssion2 Joins // OTP Eps 103

    Play Episode Listen Later Feb 28, 2025 76:22


    GLP-1 community builder Mike Donnelly-Boylen joins Dave to discuss his health mission and experience losing 100 pounds with Mounjaro! Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp

    Lilly Drops Zepbound Price, Compounders Sue FDA (again) OTP TWD 2.25.25

    Play Episode Listen Later Feb 25, 2025 22:31


    Lilly releases higher dose Zepbound vials, reduces price for patients paying out of pocket. Meanwhile, the tirzepatide lawsuit heats up, with a potential ruing on preliminary injunction. The OFA strikes up a new battle with the FDA, suing them now over the end of the semaglutide shortage. Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp

    Compound Tirzepatide Lawsuit Update / GLP-1 Heart Health w Dr Simin Lee / OTP Eps 102

    Play Episode Listen Later Feb 21, 2025 83:25


    OTP legal expert Lee Thomas joins to discuss the latest in the compound Tirzepatide lawsuit. Dr Simin Lee joins Dave to discuss obesity, GLP-1 medications and heart health! Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp

    503A Compound Tirzepatide Deadline Is Here, What Next? // OTP TWD 2.18.25

    Play Episode Listen Later Feb 18, 2025 23:05


    Zepbound Weight Loss and Cancer Diagnosis // OTP Eps 101

    Play Episode Listen Later Feb 14, 2025 90:22


    On the 101st episode of On The Pen Live, Dave discusses this week's news in GLP-1, we get weight loss maintenance tips from Korrie, and a Reddit recap from @FitFlavorFun ! For the interview portion, Dave welcomes Charles aka @RoundMoundofZepbound to discuss his health story as well as dealing with a cancer diagnosis after Zepbound weight loss. Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp

    Lilly Announces Next Gen Tirzepatide

    Play Episode Listen Later Feb 11, 2025 30:52


    Breaking Compound Tirzepatide News Lilly announces next generation of GLP-1 / GIP med Trump advocates for cheaper "Fat Shot" HIMS faces industry scrutiny Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp

    GLP-1 Talk Show: An Emotional 100th On The Pen Live

    Play Episode Listen Later Feb 7, 2025 73:37


    In the 100th episode of On The Pen Live, BJ Davis shares his inspiring 158 lb weight loss journey using Mounjaro, revealing how GLP-1 medications, exercise, and lifestyle changes transformed his life. With insights into the power of community support and expert advice, this milestone episode is a must-listen for anyone interested in sustainable weight loss and the role of GLP-1s in long-term health success! First Episode with BJ: https://www.youtube.com/live/ZrTZGwbNW98 Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp

    Zepbound and Retatrutide News: Lilly Q4 Earnings Call Recap

    Play Episode Listen Later Feb 6, 2025 33:03


    Dave Knapp breaks down what the Q4 Eli Lilly earnings call means for patients living with obesity. https://www.onthepen.com/post/lilly-s-earnings-call-could-reveal-big-changes-for-zepbound-retatrutide-what-they-ve-said-and-wha Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp

    Novo Nordisk Q4 '24 Earnings Call: Obesity Medicine Implications

    Play Episode Listen Later Feb 5, 2025 36:47


    From high dose semaglutide to cagrisema launch dates, Dave Knapp discusses how the latest Novo Nordisk earnings call impacts patients. Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp

    Like Retatrutide But In A Pill? OTP TWD 2.4.25

    Play Episode Listen Later Feb 4, 2025 24:02


    Dave covers this week's news in GLP-1 and anti-obesity medicine news. #RETATRUTIDE #ENOBARSARM #zepbound Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp

    463 Pound Zepbound Weight Loss // OTP Eps 99

    Play Episode Listen Later Feb 2, 2025 89:05


    Jamie has lost 463 pounds combining #Ozempic then #Mounjaro #Tirzepatide and Weight Loss Surgery. Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp

    503b Compounder Rocked by FDA Audit + OFA v FDA Trial Update

    Play Episode Listen Later Jan 30, 2025 20:02


    Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp

    Kelly Matthew of GLP1 Real Talk Joins! OTP Eps 97

    Play Episode Listen Later Jan 27, 2025 88:08


    Massive Zepbound and Wegovy News // OTP TWD 1.21.25

    Play Episode Listen Later Jan 21, 2025 20:55


    Lilly to offer higher doses of #Zepbound for less money? New obesity definition High dose #Wegovy trial data APC releases FDA info on enforcement of compounded #tirzepatide Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp

    TikTok GLP-1 Refugees Episode

    Play Episode Listen Later Jan 17, 2025 64:33


    With the impending TikTok ban, Dave has invited TikTok creators who are migrating to YouTube to share a little bit about their GLP-1 content that they will be offering on their new channels! #zepbound #mounjaro #tirzeptatide Links To New Creators: @chanelzway @Mike.on.a.Mission2 @mydarlingdaisyhello @jacklemay03 @the_designgirl @breena_727 @Shayla_Kay @TheGLP1HolisticQueen @KeriLeighParker-Mast @lv_doestirzeppy @lisaborders70 @glp1realtalk @Wellness.Scrummaster @GLP1Collective @BrianRantsAboutStuff https://www.obesityaction.org/action-center/access-issues/CMSPublicCommentJanuary2025 Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp

    Compounders Win Small Battle in War Over Zepbound and Mounjaro Shortages

    Play Episode Listen Later Jan 15, 2025 25:11


    https://www.onthepen.com/post/compounders-win-small-battle-in-war-over-zepbound-and-mounjaro-shortages https://www.onthepen.com/post/compounders-win-small-battle-in-war-over-zepbound-and-mounjaro-shortages https://www.obesityaction.org/action-center/access-issues/CMSPublicCommentJanuary2025 Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp

    Legal Expert: Compound Tirzepatide Trial Update || OTP Eps 96

    Play Episode Listen Later Jan 10, 2025 104:16


    Our good friend OTP legal correspondant @LeeFitsIn joins us to give us his expert take on the current lawsuit over the #Zepbound and #Mounjaro shortage lawsuit. Tag Sirius on these posts: https://www.tiktok.com/t/ZP8FAtdpe/ https://www.instagram.com/p/DEniQ5NyRPc/?igsh=bnJrZGZ3ZXpzOWcx https://forum.policiesforpeople.com/t/compound-tirzepatide-and-semaglutide-transparency-in-fda-drug-shortage-process-503b-protection/7821 Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp

    Generic Liraglutide and GLP-1 Accessibility

    Play Episode Listen Later Jan 8, 2025 23:51


    Dave brings you up to speed on the latest for all GLP-1 compounded medications. https://www.onthepen.com/post/zepound-and-mounjaro-shortage-judge-makes-shocking-move https://forum.policiesforpeople.com/t/compound-tirzepatide-and-semaglutide-transparency-in-fda-drug-shortage-process-503b-protection/7821 Decoding GLP-1: A Guide for Friends and Family of Those On The Pen By Dave Knapp

    More Generic GLP-1 Options Hit The Market!

    Play Episode Listen Later Dec 30, 2024 41:24


    Send us a textIn this special Christmas Eve Eve episode of On The Pen: The Weekly Dose, host Dave Knapp dives into groundbreaking updates in GLP-1 medication news, including terzepatide's FDA recognition for resolving obstructive sleep apnea, which could revolutionize insurance coverage for Zepbound. The podcast covers expanded access to generic liraglutide, highlighting its affordability and potential impact on maintenance therapy for obesity and diabetes. Dave also discusses Eli Lilly's victory against unauthorized terzepatide imports, emphasizing patient safety while critiquing the company's approach to compounded medications. Updates on Novo Nordisk's Cagrisema trials reveal investor disappointment despite significant weight-loss results, sparking comparisons with Terzepatide and emerging competitors like Retatrutide. The episode wraps up with exciting giveaways, a review of Dave's book Decoding GLP-1, and insights into protein intake's role in preventing hair loss during rapid weight loss. For the latest in GLP-1 treatments, giveaways, and expert insights, this podcast is your ultimate resource.Decoding GLP-1: A Guide for Friends and Family of Those On The PenBy Dave Knapp

    On The Pen: The Weekly Dose 12.17.24

    Play Episode Listen Later Dec 17, 2024 25:46


    Send us a textBuy The BooK!https://amzn.to/3Bzs4Ggro.co/OTPSupport the showOur Book Has Been Released!Decoding GLP-1: A Guide for Friends and Family of Those On The PenBuy Here: https://amzn.to/3Dc66d4DNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTPUSE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:Venmo: OnThePenCa$h App: ManOnMounjaroBECOME A MEMBER:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    An Inflatable Stomach Balloon for Weight Loss

    Play Episode Listen Later Dec 16, 2024 56:57


    Send us a textIn this special episode of the On The Pen Podcast, I sit down with Shantanu Gaur, the visionary CEO and co-founder of Allurion, to dive deep into the science and innovation behind the Allurion Balloon—a non-surgical, FDA-approved weight loss solution that's transforming the way we approach obesity treatment.We discuss the technology behind this swallowable gastric balloon, its role in reducing food intake and promoting sustainable weight loss, and how Allurion combines cutting-edge tools like a digital companion app, connected scale, and health tracker to support long-term success. Shantanu also shares insights into the company's mission to make weight loss accessible and the future of non-invasive obesity treatments.Whether you're considering weight loss options or curious about the next big leap in obesity care, this episode is packed with expert insights and actionable information. Tune in to learn more about how the Allurion Balloon is helping people achieve transformative results without surgery, and why Shantanu Gaur believes this could be a game-changer in the fight against obesity.ro.co/OTPSupport the showOur Book Has Been Released!Decoding GLP-1: A Guide for Friends and Family of Those On The PenBuy Here: https://amzn.to/3Dc66d4DNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTPUSE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:Venmo: OnThePenCa$h App: ManOnMounjaroBECOME A MEMBER:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    A GLP-1 Monopoly In The Making: Biden Admin Fails to Act, Novo Acquires Catalent

    Play Episode Listen Later Dec 14, 2024 10:19


    Send us a texthttps://www.onthepen.com/post/novo-nordisk-catalent-deal-approvedSupport the showOur Book Has Been Released!Decoding GLP-1: A Guide for Friends and Family of Those On The PenBuy Here: https://amzn.to/3Dc66d4DNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTPUSE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:Venmo: OnThePenCa$h App: ManOnMounjaroBECOME A MEMBER:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    OFA Representation in Compound Tirzepatide Case Sits Down with OTP

    Play Episode Listen Later Dec 11, 2024 19:14


    Send us a textSupport the showDNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTPUSE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:Venmo: OnThePenCa$h App: ManOnMounjaroBECOME A MEMBER:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    CagriSema Delay? Novo Catalent Update

    Play Episode Listen Later Dec 11, 2024 21:56


    Send us a textSupport the showDNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTPUSE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:Venmo: OnThePenCa$h App: ManOnMounjaroBECOME A MEMBER:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    American Diabetes Association on the Wrong Side of Compounded GLP-1 Meds

    Play Episode Listen Later Dec 3, 2024 21:02


    Send us a texthttps://diabetes.org/newsroom/press-releases/american-diabetes-association-announces-statement-compounded-incretinSupport the showDNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTPUSE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:Venmo: OnThePenCa$h App: ManOnMounjaroBECOME A MEMBER:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    Like Ozempic, But You Only Take It Once! Fractyl Health CEO Dr. Harith Rajagopalan

    Play Episode Listen Later Nov 29, 2024 38:56


    Send us a textCEO and Co-Founder of Fractyl Health ($GUTS) Dr. Harith Rajagopalan joins On The Pen to discuss their #Revita and #Rejuva programs for type 2 diabetes and obestityhttps://www.fractyl.com/ro.co/OTPSupport the showDNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTPUSE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:Venmo: OnThePenCa$h App: ManOnMounjaroBECOME A MEMBER:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    Retatrutide Cagrisema & Obesity Medicine Future With Dr. Michael Albert

    Play Episode Listen Later Nov 28, 2024 86:48


    Send us a textDr Michael Albert and Dave Knapp discuss the current events in GLP-1 medications as well as the horizon of future anti obesity medicine.ro.co/OTPSupport the showDNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTPUSE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:Venmo: OnThePenCa$h App: ManOnMounjaroBECOME A MEMBER:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    Medicare to Cover Zepbound and Wegovy?

    Play Episode Listen Later Nov 26, 2024 22:41


    Send us a texthttps://www.onthepen.com/post/medicare-medicaide-to-cover-zepbound-here-s-why-it-s-not-as-simple-as-it-soundsro.co/OTPSupport the showDNF10 Peptide Supplement I Use: https://integrativepeptides.com/AFFILITATES/OTPUSE CODE "OTP10" to save 10%. A small commission is paid back to support On The Pen!MY WORK RELIES ON YOUR GENEROSITY, WAYS TO SUPPORT:Venmo: OnThePenCa$h App: ManOnMounjaroBECOME A MEMBER:https://www.youtube.com/channel/UCDocQ-4IhVS3ihy_dW7nSKw/join

    Claim On The Pen: The Weekly Dose

    In order to claim this podcast we'll send an email to with a verification link. Simply click the link and you will be able to edit tags, request a refresh, and other features to take control of your podcast page!

    Claim Cancel